← Open Payments lookup

REBECCA REED: Open Payments

NPI 1417349572 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,149 in 99 payments from 28 companies in 2025. Trend: 2023 $927 · 2024 $2,290 · 2025 $2,149

Food & beverage: $2,068Education: $80
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP20$390
GlaxoSmithKline, LLC.16$266
GENZYME CORPORATION8$231
Regeneron Healthcare Solutions, Inc.3$151
United Therapeutics Corporation5$141
Dexcom, Inc.4$96
Verona Pharma, Inc.4$71
Takeda Pharmaceuticals U.S.A., Inc.3$67
Avadel CNS Pharmaceuticals, LLC3$64
ANI Pharmaceuticals, Inc.3$63

Products named: DUPIXENT, FASENRA, NUCALA, Tyvaso, TRELEGY ELLIPTA, Dexcom G6 Transmitter, TEZSPIRE, AIRSUPRA.

Industry payments across SC — which companies pay providers there.